On September 21, 2018, the Canada Border Services Agency (CBSA) announced that it has launched an investigation under the Special Import Measures Act (SIMA) respecting the alleged injurious dumping of certain nitisinone capsules from Sweden.
The investigation follows a complaint filed by Laboratoires KABS Inc. and MendeliKABS Inc.
Subsequently on September 24, 2018, the Canadian International Trade Tribunal (CITT) gave notice that it has initiated an injury inquiry to determine if the alleged dumping of the nitisinone capsules specified above has caused injury or retardation or is threatening to cause injury to Canadian manufacturers.
The goods being investigated are described as capsules and tablets of nitisinone with a dosage of 2 mg, 5 mg, 10 mg and 20 mg, whether or not they are packaged for retail, originating in or exported from Sweden.
The subject goods are usually classified under HS classification numbers 3004.90.00.79, 3004.90.00.90 or 3003.90.00.90. However, these classification numbers are for ease of reference only. Refer to Appendix 1 of the CBSA notice for the authoritative details regarding the subject goods.
Parties wishing to participate in the preliminary injury inquiry must file a notice of participation with the CITT on or before October 4, 2018.
Written submissions & requests for information should be sent to:
The Registrar, Secretariat to the Canadian International Trade Tribunal
15th Floor, 333 Laurier Avenue West
Ottawa, Ontario K1A 0G7
Telephone: 613-993-3595
Email : citt-tcce@tribunal.gc.ca
Additional Information on the injury inquiry including specifications and a preliminary inquiry schedule is found in the CITT Notice of Preliminary Injury Inquiry.
Questions concerning the initial CBSA investigation should be directed to the following CBSA officers:
Hugo Dumas: 613-948-8581
Mathew Lerette: 613-954-7398
More information on the investigation can be found on the Canada Border Services website.
Please contact your Livingston account representative should you have any questions.